EVOC
LIVE

Serial Number

79258342

Owner

Owlstone Medical Limited

Attorney

Feng Shan

Filing Date

Dec 13, 2018

Add to watchlist:

No watchlists yet
View on USPTO

EVOC Trademark

Serial Number: 79258342 • Registration: 6098300

EVOC is a trademark filed by Owlstone Medical Limited on December 13, 2018. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Owlstone Medical Limited (15 trademarks)

183 Cambridge Science Park,

Entity Type: 99

Trademark Details

Filing Date

December 13, 2018

Registration Date

July 14, 2020

Published for Opposition

March 17, 2020

Goods & Services

Medical research services; Clinical research services in the field of disease biomarkers; Chemical analysis; Chemical research; Analytical laboratory services in the field of disease biomarkers; Biological analysis; Laboratory analysis in the field of disease biomarkers; Scientific laboratory services; Laboratory testing services of disease biomarkers within gas, liquid and solid samples; Medical research laboratory services; Design and development of medical technology and medical apparatus research and development services relating to medical apparatus and instruments; Advice, information and consultancy relating to any of the aforesaid scientific laboratory services; none of the aforesaid relating to dermatology or skincare; none of the aforesaid relating to vehicles or the automotive industry

Medical apparatus and instruments for treating cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, fatty liver disease; Diagnostic apparatus for medical purposes for detecting cancer cells; Chemical detection systems and apparatus for medical purposes, namely, analyzers and sampling equipment for use to collect and analyze liquid, solid and gas samples; Medical imaging apparatus; Medical and clinical devices used for the collection, recording, concentration and analysis of volatile organic compounds in human breath; Medical testing kits in the nature of a medical device for detection of cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, fatty liver disease for home use; Respiratory equipment for medical purposes; Testing apparatus for medical purposes, namely, breath detectors for use to detect disease biomarkers; Detectors for medical purposes, namely, breath detectors for use to detect disease biomarkers; Sensors for medical purposes, namely, respiratory sensors; Replacement parts and fittings for all of the aforesaid; none of the aforesaid relating to dermatology or skincare; none of the aforesaid goods being related to hip prosthesis or orthopaedic articles

Medical services; Consulting services relating to health care; Healthcare services; health advice and information services; Medical care services; Medical clinic services; health clinic services; Medical health assessment services; Health screening services in the field of cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, fatty liver disease; Diagnostic health screening services in the field of cancer, celiac disease, tuberculosis, asthma, inflammatory bowel disease, fatty liver disease; providing health information in the form of preparing reports relating to health matters; Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic purposes; Genetic testing for medical purposes; advice, information and consultancy services relating to any of the aforesaid medical services; none of the aforesaid relating to dermatology or skincare

Downloadable and recorded computer software and computer programs to control collection of medical samples by modifying the timing of data collection and to perform analysis of medical samples in connection with and as part of medical apparatus; Downloadable and recorded computer application software for hand-held computing devices, namely, software to control collection of medical samples and to perform analysis of medical samples for use in connection with and as part of medical apparatus and instruments; Downloadable and recorded medical diagnostic software for use to control collection of medical samples and to perform analysis of medical samples in connection with and as part of medical apparatus and instruments; Chemical detection systems and apparatus, namely, analyzers and sampling equipment for use to collect and analyze liquid, solid and gas samples; gas detectors for detecting the presence of gas; Particle counters; Pressure sensors; Downloadable and recorded computer software and computer programs for medical purposes for use to diagnose and monitor diseases in connection with and as part of medical apparatus and instruments; replacement parts and fittings for all of the aforesaid; none of the aforesaid relating to dermatology or skincare; none of the aforesaid relating to vehicles or the automotive industry

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 13, 2025 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 14, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 21, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 4, 2020 FICS
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Nov 4, 2020 LIMN
FINAL DISPOSITION PROCESSED
Nov 4, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 14, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 14, 2020 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jun 4, 2020 ETOP
LIMITATION OF GOODS RECEIVED FROM IB
May 1, 2020 LIMG
EXTENSION OF TIME TO OPPOSE RECEIVED
Apr 16, 2020 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 17, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 17, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Mar 13, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 26, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 26, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 26, 2020 NONP
ASSIGNED TO LIE
Feb 13, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 10, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 10, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 10, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 10, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 10, 2020 CNEA
EXAMINER'S AMENDMENT ENTERED
Feb 10, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 10, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 10, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 10, 2020 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 22, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jan 22, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jan 22, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 24, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 24, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 24, 2019 TROA
REFUSAL PROCESSED BY IB
Aug 16, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 26, 2019 RFCS
REFUSAL PROCESSED BY MPU
Jul 26, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 2, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jul 1, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
May 14, 2019 MAFR
ASSIGNED TO EXAMINER
May 10, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 10, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 9, 2019 REPR